For instance, HOXD1 was both underexpressed and hypermethylated at the promoter in BPH specimens, consistent with the downregulation of AR signaling pathway found in BPH34,35 (Fig. 2f and Supplementary Fig. 7). Here, HOXD1 is linked to benign prostatic hyperplasia.